BIOMAT Database Logo BIOMAT Database Logo

In-vitro activity of fleroxacin (Ro 23-6240), a new fluoro-quinolone, and other agents, against Mycobacterium spp. 1988

F Ernst, and P van der Auwera

UI MeSH Term Description Entries
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016576 Fleroxacin A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE. AM-833,Quinodis,Ro 23-6240,AM 833,AM833,Ro 23 6240,Ro 236240

Related Publications

F Ernst, and P van der Auwera
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
February 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
F Ernst, and P van der Auwera
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
August 1987, European journal of clinical microbiology,
F Ernst, and P van der Auwera
In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
January 1988, Chemotherapy,
F Ernst, and P van der Auwera
In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.
July 1988, Antimicrobial agents and chemotherapy,
F Ernst, and P van der Auwera
In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.
April 1986, Antimicrobial agents and chemotherapy,
F Ernst, and P van der Auwera
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
September 1987, The Journal of antimicrobial chemotherapy,
F Ernst, and P van der Auwera
In vitro activity of the new 4-quinolone compound Ro 23-6240.
April 1987, European journal of clinical microbiology,
F Ernst, and P van der Auwera
Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
February 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
F Ernst, and P van der Auwera
In vitro evaluation of Ro 23-6240, a new fluorinated 4-quinolone.
January 1987, Chemotherapy,
F Ernst, and P van der Auwera
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
August 1987, European journal of clinical microbiology,
Copied contents to your clipboard!